Stock FCM FRIULCHEM S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Friulchem S.p.A. Stock

Equities

FCM

IT0005378457

Pharmaceuticals

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-04-26 am EDT 		5-day change 1st Jan Change
0.96 EUR 0.00% Intraday chart for Friulchem S.p.A. +2.13% -4.00%
Mar. 22 Friulchem returns to profit in 2023; increases financial debt AN
Mar. 22 Friulchem S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2023 26.66M 28.5M Sales 2024 * 30.5M 32.61M Capitalization 5.76M 6.16M
Net income 2023 - 0 Net income 2024 * - 0 EV / Sales 2023 0.55 x
Net Debt 2023 8.62M 9.21M Net Debt 2024 * 12.7M 13.58M EV / Sales 2024 * 0.61 x
P/E ratio 2023 *
-24 x
P/E ratio 2024 *
-96 x
Employees 86
Yield 2023 *
-
Yield 2024 *
-
Free-Float 41.47%
More Fundamentals * Assessed data

Chart Friulchem S.p.A.

Dynamic Chart

Latest news about Friulchem S.p.A.

Friulchem returns to profit in 2023; increases financial debt AN
Friulchem S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Futures bullish; wait for PMIs to come in. AN
Mib rises; rally on listings after central banks AN
ITALY GROWTH WINNERS & LOSERS: Illa and GO internet at the bottom AN
Fourth edition of NextGems kicks off Oct. 17 and 18 AN
Friulchem in half-year increases profit; sales revenues down AN
Friulchem S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Piazza Affari mixed; Italy PPI expected AN
Futures predict a downward opening AN
Milan in 29,600-point area; STM soars after accounts AN
Mib veers upward; banks act as locomotive AN
Stock markets start bearish; buying on FinecoBank AN
Futures positive; wait for central banks AN
Business Square in the green; top to Mediobanca on the Mib. AN
More news

Press releases Friulchem S.p.A.

FRIULCHEM CONSOLIDATES ITS PRESENCE IN CHINA: REGISTERED TWO PRODUCTS FROM THE SUPPLEO LINE DEVELOPED BY FRIULCHEM USING FC- Cubes® TECHNOLOGY AND ANNOUNCEMENT OF FRIULCHEM’S PARTICIPATION AT PET FAIR CHINA 2023 IN SHANGHAI PU
Friulchem S p A : Euronext Growth Conference PU
Friulchem S p A : SIGNS AN AGREEMENT WITH AN ITALIAN PHARMACEUTICAL COMPANY PU
Friulchem S p A : AIM CONFERENCE 2021 PU
Friulchem S p A : INVESTMENT TO SUPPORT BUSINESS CONTINUATION RELATING TO THE COVID-19 HEALTH EMERGENCY PU
More press releases

News in other languages on Friulchem S.p.A.

Friulchem torna in utile nel 2023; aumenta indebitamento finanziario
Future rialzisti; attesa per l'arrivo dei PMI
Mib sale; rally sui listini dopo banche centrali
L'agenda di oggi -2-
COMMENTO EGM : indice chiude in rialzo, bene Innovatec e Redelfi
More news

Quotes and Performance

1 week+2.13%
Current month-2.04%
1 month-2.04%
3 months-7.69%
6 months-10.28%
Current year-4.00%
More quotes

Highs and lows

1 week
0.96
Extreme 0.96
1.04
1 month
0.91
Extreme 0.905
1.04
Current year
0.91
Extreme 0.905
1.05
1 year
0.91
Extreme 0.905
1.21
3 years
0.91
Extreme 0.905
1.41
5 years
0.91
Extreme 0.905
1.97
10 years
0.91
Extreme 0.905
1.97
More quotes

Managers and Directors - Friulchem S.p.A.

Managers TitleAgeSince
Disma Giovanni Mazzola CEO
 Chief Executive Officer 50 -
Carlo Marelli DFI
 Director of Finance/CFO 51 08-12-31
Silvia Moiana COO
 Chief Operating Officer 48 -
Members of the board TitleAgeSince
Ariel Davide Segre BRD
 Director/Board Member 85 19-06-27
Roberta Terpin BRD
 Director/Board Member 46 -
Disma Giovanni Mazzola CEO
 Chief Executive Officer 50 -
More insiders

Quotes

Date Price Change Volume
24-04-26 0.96 0.00% 0
24-04-25 0.96 0.00% 0
24-04-24 0.96 -2.04% 6,750
24-04-23 0.98 0.00% 12,750
24-04-22 0.98 +4.26% 7,500

Real-time Borsa Italiana, April 26, 2024 at 11:44 am EDT

More quotes

Company Profile

Friulchem SpA is an Italy-based private chemical-pharmaceutical company dealing with research, development and production of pharmaceutical products for both human and veterinary fields.
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Ratings for Friulchem S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.96 EUR
Average target price
1.2 EUR
Spread / Average Target
+25.00%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FRIULCHEM S.P.A. Stock Friulchem S.p.A.
-4.00% 6.15M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. FCM Stock